Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression.

Whole exome sequencing was performed in a patient with myelodysplastic syndrome before and after progression to acute myeloid leukaemia. Mutations in several genes, including SETBP1, were identified following leukaemic transformation. Screening of 328 patients with myeloid disorders revealed SETBP1...

Ful tanımlama

Detaylı Bibliyografya
Asıl Yazarlar:	Fernandez-Mercado, M, Pellagatti, A, Di Genua, C, Larrayoz, M, Winkelmann, N, Aranaz, P, Burns, A, Schuh, A, Calasanz, M, Cross, N, Boultwood, J
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	2013

Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression Yazar: Fernandez-Mercado, M, Pellagatti, A, Di Genua, C, Larrayoz, M, Winkelmann, N, Aranaz, P, Burns, A, Schuh, A, Calasanz, M, Cross, N, Boultwood, J

Baskı/Yayın Bilgisi 2013

Journal article

Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression.

Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression Yazar: Fernandez-Mercado, M, Pellagatti, A, Di Genua, C, Larrayoz, M, Winkelmann, N, Aranaz, P, Burns, A, Schuh, A, Calasanz, M, Cross, N, Boultwood, J

Benzer Materyaller